1-phenylcyclohexan-1-amine hydrochloride (PCA HCl) alters mesolimbic dopamine system accompanied by neuroplastic changes: A neuropsychopharmacological evaluation in rodents

Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents

(2020) Raly James Perez Custodio et al.   JOURNAL OF PSYCHOPHARMACOLOGY

4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels

(2019) Arvie Abiero et al.   PSYCHOPHARMACOLOGY

Two Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine

(2017) Monika Zidkova et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity

(2017) A. Ahnaou et al.   Translational Psychiatry

The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents

(2016) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

The role of serotonin in drug use and addiction

(2015) Christian P. Müller et al.   BEHAVIOURAL BRAIN RESEARCH

Brain-derived neurotrophic factor and addiction: Pathological versus therapeutic effects on drug seeking

(2015) Jacqueline M. Barker et al.   BRAIN RESEARCH

The Brain on Drugs: From Reward to Addiction

(2015) Nora D. Volkow et al.   CELL

Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential

(2015) Chrislean Jun Botanas et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

(2014) Hamilton Morris et al.   Drug Testing and Analysis

Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues

(2013) Jason Wallach et al.   Drug Testing and Analysis

A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo

(2013) Mark J Hunt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rewarding and reinforcing effects of the NMDA receptor antagonist–benzodiazepine combination, zoletil®: Difference between acute and repeated exposure

(2012) June Bryan I. de la Peña et al.   BEHAVIOURAL BRAIN RESEARCH

Transcriptional Mechanisms of Drug Addiction

(2012) Eric J. Nestler   Clinical Psychopharmacology and Neuroscience

Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power

(2011) Nigel C. Jones et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

EEG delta oscillations as a correlate of basic homeostatic and motivational processes

(2011) Gennady G. Knyazev   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Ketamine Modulates Theta and Gamma Oscillations

(2009) Maciej T. Lazarewicz et al.   JOURNAL OF COGNITIVE NEUROSCIENCE

Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction

(2008) B. J Everitt et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Characterization of methylphenidate self-administration and reinstatement in the rat

(2008) Leigh C. P. Botly et al.   PSYCHOPHARMACOLOGY